Yong-Hoon Chung, MD, Ph.D., Added to the Prestigious Roster of Korean Albert Nelson Marquis Lifetime Achievement Inductees

Dr. Yong-Hoon Chung has been endorsed by Marquis Who’s Who as a Korean leader in the medical industry

News provided by Marquis Who's Who
Jan 24, 2019 12:00 KST

SEOUL--(Korea Newswire) January 24, 2019 -- Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Yong-Hoon Chung, MD, Ph.D., with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Chung celebrates many years’ experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

With 37 years of professional experience, Dr. Yong-Hoon Chung has been president and chief executive officer of MedExGen, Inc., since 2000 and a professor of medical microbiology and immunology at the Hanyang University College of Medicine since 1986. In addition to his primary roles, he served as a board member with the Korean Society for Microbiology and Biotechnology from 1993 to 2006, chair of the department of microbiology at Hanyang University from 1998 to 2004, board director at Boryung Pharmaceutical Company Ltd. from 1997 to 2000, and director general of the Korean Association of Immunologists from 1994 to 1997.

A leading voice in the industry, Dr. Yong-Hoon Chung has held a Medical Doctor degree since 1982 and a Doctor of Philosophy degree since 1988 from Hanyang University. He has been an active member of his community and has been affiliated with the Review Committee of Science and Technology.

Since 1997 his research has focused on various innovative platform technologies on developments for better biological therapeutics. These are enabling to provide unmet needs of current biologics on both the patient and industry side. He holds patents for methods of increasing efficacy and potency of cytokines and immunoadhesins and glycosylation modifications on immunoglobulin types of drugs, as well as several pending patents in the field. Recently he added highly metallated botulinum neurotoxin with beneficial therapeutic features to his list of inventions.

Throughout his career, Dr. Chung has been recognized for his contributions, including having been named Doctor of the Year by Hanil General Hospital. A grantee of the Korean government, he was the recipient of a Gochon Medical Scholarship from Chong-Keun Dang Pharmaceutical Company. He has been featured in numerous honors publications, including the first edition of Who’s Who in Asia and the 25th edition of Who’s Who in the World.

About Marquis Who’s Who®

Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.

Website: https://www.marquiswhoswho.com/


Marquis Who’s Who
Fred Marks

This is a news release distributed by Korea Newswire on behalf of this company. Learn more